유비케어
Financials
Valuation Metrics
유비케어's Market Cap is ₩1626B. At end of 2025 it was ₩1905B. Ranked #974 of 2,421 in KR market (top 40%), #482 of 1,640 on KOSDAQ (top 29%), #30 of 96 in Health Care Equipment & Services (top 31%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 162.59B KRW | KR#974/2,421 Sec#30/96 |
| Revenue | 205.08B KRW | KR#1,017/2,421 Sec#12/96 |
| Net Income | -569.9M KRW | KR—/2,421 Sec—/96 |
| Total Assets | 230.58B KRW | KR#1,213/2,421 Sec#32/96 |
| Net Assets | 160.44B KRW | KR#1,095/2,421 Sec#30/96 |
| Employees | 338 | KR#709/2,421 Sec#18/96 |
| Value | ||
| P/B | 1.01x | KR#1,476/2,421 Sec#42/96 |
| P/S | 0.79x | KR#1,236/2,421 Sec#20/96 |
| EV/EBITDA | 12.83x | KR#758/2,421 Sec#25/96 |
| Profitability | ||
| ROE | -0.36% | KR#1,572/2,421 Sec#50/96 |
| ROA | -0.25% | KR#1,581/2,421 Sec#51/96 |
| Op. Margin | 5.94% | KR#843/2,421 Sec#37/96 |
| Revenue Growth | 6.53% | KR#1,104/2,421 Sec#62/96 |
| Earnings Growth | -101.40% | KR#1,148/2,421 Sec#39/96 |
| Financial Health | ||
| Debt Ratio | 43.71% | KR#863/2,421 Sec#45/96 |
| Total Debt | 7.34B KRW | KR#1,717/2,421 Sec#58/96 |
| Cash | 13.67B KRW | KR#1,492/2,421 Sec#45/96 |
| Current Ratio | 1.89x | KR#924/2,421 Sec#55/96 |
| Net Debt/EBITDA | -0.52x | KR#487/2,421 Sec#20/96 |
| Dividend | ||
| Div. Yield | 1.60% | KR#973/2,421 Sec#27/96 |
| Div. Growth | 66.67% | KR#179/2,421 Sec#10/96 |
| Performance | ||
| 1Y Return | -27.56% | KR#1,484/2,421 Sec#35/96 |
| 1M Return | 3.83% | KR#849/2,421 Sec#23/96 |
| From 52W High | -29.04% | KR#500/2,421 Sec#15/96 |
| 1Y MDD | -38.11% | KR#517/2,421 Sec#14/96 |
| Trading | ||
| Volume | 49,627 shares | KR#1,138/2,421 Sec#39/96 |
| Trading Value | 155.0M KRW | KR#1,362/2,421 Sec#57/96 |
| Foreign Own. | 2.08% | KR#1,599/2,421 Sec#59/96 |
| Per Share | ||
| EPS | -11 KRW | KR—/2,421 Sec—/96 |
| BPS | 3,074 KRW | KR#1,845/2,421 Sec#58/96 |
Company Info
Established in 1994 and listed on KOSDAQ in 1997, this company developed Korea's first EMR (Electronic Medical Record) system. It boasts a network of approximately 26,000 medical institutions nationwide, offering EMR solution development and supply, healthcare big data analysis, pharmaceutical marketing platform operations, and the distribution and manufacturing of medical consumables, pharmaceuticals, and equipment. The company also provides patient and silver care platform services, and is currently building an integrated medical platform through services such as 'Ttokktok' for medical consultations, 'Doctorvice' for chronic disease management, and 'Ttohanauigajok' for silver care. Ubicare is headquartered in Seongdong-gu, Seoul Special City.